ag-1296 has been researched along with Prostatic Neoplasms in 3 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report that prostate cancer cells that metastasize to the skeleton respond to human bone marrow with a robust stimulation of the phosphatidylinositol 3-kinase/Akt pathway, whereas prostate cells that lack bone-metastatic potential respond negligibly." | 1.34 | Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor. ( Dolloff, NG; Fatatis, A; Loizos, N; Russell, MR, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skogseth, H | 1 |
| Larsson, E | 1 |
| Halgunset, J | 1 |
| Le Page, C | 1 |
| Koumakpayi, IH | 1 |
| Lessard, L | 1 |
| Saad, F | 1 |
| Mes-Masson, AM | 1 |
| Dolloff, NG | 1 |
| Russell, MR | 1 |
| Loizos, N | 1 |
| Fatatis, A | 1 |
3 other studies available for ag-1296 and Prostatic Neoplasms
| Article | Year |
|---|---|
Inhibitors of tyrosine kinase inhibit the production of urokinase plasminogen activator in human prostatic cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Genistein; Humans; Male; Prostatic Neoplasms; | 2005 |
Independent role of phosphoinositol-3-kinase (PI3K) and casein kinase II (CK-2) in EGFR and Her-2-mediated constitutive NF-kappaB activation in prostate cancer cells.
Topics: Blotting, Western; Casein Kinase II; Cell Line, Tumor; Chromones; Electrophoretic Mobility Shift Ass | 2005 |
Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor.
Topics: Adolescent; Adult; Animals; Antibodies, Monoclonal; Antibody Specificity; Becaplermin; Bone Marrow; | 2007 |